These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 30324476)

  • 1. ASO Author Reflections: Role of Contrast-Enhanced Spectral Mammography in the Assessment of Residual Breast Cancer After Neoadjuvant Systemic Therapy.
    Hilal T; Patel BK
    Ann Surg Oncol; 2018 Dec; 25(Suppl 3):652-653. PubMed ID: 30324476
    [No Abstract]   [Full Text] [Related]  

  • 2. Contrast-enhanced spectral mammography in neoadjuvant chemotherapy monitoring: a comparison with breast magnetic resonance imaging.
    Iotti V; Ravaioli S; Vacondio R; Coriani C; Caffarri S; Sghedoni R; Nitrosi A; Ragazzi M; Gasparini E; Masini C; Bisagni G; Falco G; Ferrari G; Braglia L; Del Prato A; Malavolti I; Ginocchi V; Pattacini P
    Breast Cancer Res; 2017 Sep; 19(1):106. PubMed ID: 28893303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contrast-Enhanced Spectral Mammography is Comparable to MRI in the Assessment of Residual Breast Cancer Following Neoadjuvant Systemic Therapy.
    Patel BK; Hilal T; Covington M; Zhang N; Kosiorek HE; Lobbes M; Northfelt DW; Pockaj BA
    Ann Surg Oncol; 2018 May; 25(5):1350-1356. PubMed ID: 29516362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic accuracy of mammography, ultrasonography and magnetic resonance imaging in the detection of intraductal spread of breast cancer following neoadjuvant chemotherapy.
    Kubota K; Ogawa Y; Nishioka A; Kariya S; Itoh S; Murata Y; Hamada N; Maeda H; Tanaka Y
    Oncol Rep; 2007 Apr; 17(4):915-8. PubMed ID: 17342336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparing Accuracy of Mammography and Magnetic Resonance Imaging for Residual Calcified Lesions in Breast Cancer Patients Undergoing Neoadjuvant Systemic Therapy.
    Um E; Kang JW; Lee S; Kim HJ; Yoon TI; Sohn G; Chung IY; Kim J; Lee JW; Son BH; Ahn SH; Ko BS
    Clin Breast Cancer; 2018 Oct; 18(5):e1087-e1091. PubMed ID: 29703689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ASO Author Reflections: Role of Genomic Assay to Predict Neoadjuvant Chemotherapy Response in Breast Cancer.
    Pease AM; James TA
    Ann Surg Oncol; 2019 Dec; 26(Suppl 3):573-574. PubMed ID: 30783852
    [No Abstract]   [Full Text] [Related]  

  • 7. ASO Author Reflections: Elimination of Breast Cancer Surgery in Complete Responders After Neoadjuvant Chemotherapy: Imaging Perspective.
    Rauch GM
    Ann Surg Oncol; 2018 Dec; 25(Suppl 3):628-629. PubMed ID: 30244417
    [No Abstract]   [Full Text] [Related]  

  • 8. Assessment of Residual Disease With Molecular Breast Imaging in Patients Undergoing Neoadjuvant Therapy: Association With Molecular Subtypes.
    Menes TS; Golan O; Vainer G; Lerman H; Schneebaum S; Klausner J; Even-Sapir E
    Clin Breast Cancer; 2016 Oct; 16(5):389-395. PubMed ID: 27282845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ASO Author Reflections: Use of Breast Imaging After Treatment for Locoregional Breast Cancer (AFT-01).
    Adesoye T; Schumacher J; Greenberg CC
    Ann Surg Oncol; 2019 Dec; 26(Suppl 3):553-554. PubMed ID: 30565039
    [No Abstract]   [Full Text] [Related]  

  • 10. ASO Author Reflections: Moving Forward De-escalation of Axillary Surgery After Neoadjuvant Treatment in Breast Cancer.
    Rubio IT
    Ann Surg Oncol; 2018 Dec; 25(Suppl 3):638-639. PubMed ID: 30284130
    [No Abstract]   [Full Text] [Related]  

  • 11. Meta-analysis of magnetic resonance imaging in detecting residual breast cancer after neoadjuvant therapy.
    Marinovich ML; Houssami N; Macaskill P; Sardanelli F; Irwig L; Mamounas EP; von Minckwitz G; Brennan ME; Ciatto S
    J Natl Cancer Inst; 2013 Mar; 105(5):321-33. PubMed ID: 23297042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Newly Diagnosed Breast Cancer: Comparison of Contrast-enhanced Spectral Mammography and Breast MR Imaging in the Evaluation of Extent of Disease.
    Lee-Felker SA; Tekchandani L; Thomas M; Gupta E; Andrews-Tang D; Roth A; Sayre J; Rahbar G
    Radiology; 2017 Nov; 285(2):389-400. PubMed ID: 28654337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ASO Author Reflections: The Role of Imaging Modalities in Omitting Surgery in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy.
    Palshof FK; Kroman N; Tvedskov TF
    Ann Surg Oncol; 2021 Nov; 28(12):7430-7431. PubMed ID: 34023947
    [No Abstract]   [Full Text] [Related]  

  • 14. ASO Author Reflections: Prediction of Implant Size Based on Breast Volumetry Using Mammography and Breast MRI in DTI Breast Reconstruction.
    Kim YS; Cho HG; Kim J; Park SJ; Kim HJ; Lee SE; Yang JD; Kim WH; Lee JS
    Ann Surg Oncol; 2022 Nov; 29(12):7855-7856. PubMed ID: 35717517
    [No Abstract]   [Full Text] [Related]  

  • 15. ASO Author Reflections: Bilateral Mastectomy After Neoadjuvant Therapy: An Ever-Increasing Trend?
    Kantor O; Yao K
    Ann Surg Oncol; 2018 Dec; 25(Suppl 3):650-651. PubMed ID: 30327968
    [No Abstract]   [Full Text] [Related]  

  • 16. ASO Author Reflections: Residual Disease in the Breast After Neoadjuvant Chemotherapy Does Not Mandate Routine Post-Mastectomy Radiation Therapy/Regional Nodal Irradiation.
    Crown A; Morrow M
    Ann Surg Oncol; 2021 Mar; 28(3):1336-1337. PubMed ID: 32920718
    [No Abstract]   [Full Text] [Related]  

  • 17. Identification of residual breast carcinoma following neoadjuvant chemotherapy: diffusion-weighted imaging--comparison with contrast-enhanced MR imaging and pathologic findings.
    Woodhams R; Kakita S; Hata H; Iwabuchi K; Kuranami M; Gautam S; Hatabu H; Kan S; Mountford C
    Radiology; 2010 Feb; 254(2):357-66. PubMed ID: 20093508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Residual microcalcifications after neoadjuvant chemotherapy for locally advanced breast cancer: comparison of the accuracies of mammography and MRI in predicting pathological residual tumor.
    An YY; Kim SH; Kang BJ
    World J Surg Oncol; 2017 Nov; 15(1):198. PubMed ID: 29110671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ASO Author Reflections: Prognostic Role of Pathologic Complete Response After Neoadjuvant Therapy in Digestive Cancer.
    Wan T; Zhou YM
    Ann Surg Oncol; 2019 Dec; 26(Suppl 3):587. PubMed ID: 31011901
    [No Abstract]   [Full Text] [Related]  

  • 20. MR imaging for assessment of breast cancer response to neoadjuvant chemotherapy.
    Hylton N
    Magn Reson Imaging Clin N Am; 2006 Aug; 14(3):383-9, vii. PubMed ID: 17098179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.